4.1 Article

An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1

Related references

Note: Only part of the references are listed.
Review Oncology

Molecular pathogenesis and prognostication of low-grade'' and high-grade endometrial stromal sarcoma

Francesca Micci et al.

Summary: Endometrial stromal sarcomas (ESS) are a rare and heterogeneous group of mesenchymal cancers, now classified as low- or high-grade. They may have overlapping clinical presentation, morphology, and immunohistochemical profile. Understanding the molecular characteristics of ESS can improve diagnosis, prognostication, and treatment.

GENES CHROMOSOMES & CANCER (2021)

Article Cell Biology

p53 immunohistochemical analysis of fusion-positive uterine sarcomas

Nissreen Mohammad et al.

Summary: This study evaluated TP53 mutations in uterine sarcomas with genetic fusions using immunohistochemistry. The majority of fusion-positive sarcomas showed wild-type p53 expression, while a small subset of sarcomas with NTRK1/3 fusion displayed mutation-type p53 expression.

HISTOPATHOLOGY (2021)

Article Pathology

Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas

Shuko Harada et al.

Summary: The study evaluated the performance of the Archer FusionPlex assay for detecting TFE3 and TFEB fusions in MiT-RCC, showing successful identification of these fusions including intrachromosomal inversions not easily detected by FISH. The mRNA expression ratio of TFEB/TFE3 may predict TFEB amplification, streamlining the testing process.

MODERN PATHOLOGY (2021)

Article Pathology

Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas

Douglas Lin et al.

Summary: BCORL1-altered uterine sarcomas show clinical and histological similarities to BCOR-ESS, with unique morphological features such as spindle and epithelioid components, myxoid stroma, collagen plaques or fibrosis, and high-grade nuclear atypia. These tumors may mimic myxoid leiomyosarcomas and have potential therapeutic targets including CDK4 amplification, CDKN2A loss, NF1 alterations, and NF2-mTOR pathway alterations.

MODERN PATHOLOGY (2021)

Article Pathology

BCOR Expression in Mullerian Adenosarcoma A Potential Diagnostic Pitfall

Vidarshi Muthukumarana et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Review Cell Biology

Uterine mesenchymal tumours: recent advances

Amir Momeni-Boroujeni et al.

HISTOPATHOLOGY (2020)

Article Pathology

Inflammatory Myofibroblastic Tumor of the Uterus An Immunohistochemical Study of 23 Cases

Jennifer A. Bennett et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Review Medical Laboratory Technology

Inflammatory Myofibroblastic Tumor in Female Genital Tract

Pratibha Sharma Shukla et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)

Article Pathology

BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas

Adrian Marino-Enriquez et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)

Article Obstetrics & Gynecology

A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1

Allison J. Allen et al.

GYNECOLOGIC ONCOLOGY REPORTS (2017)

Review Pathology

Endometrial Stromal Tumors: The New WHO Classification

Christopher M. J. Conklin et al.

ADVANCES IN ANATOMIC PATHOLOGY (2014)

Article Pathology

MED12 mutations in leiomyosarcoma and extrauterine leiomyoma

Gloria Ravegnini et al.

MODERN PATHOLOGY (2013)

Review Multidisciplinary Sciences

The Polycomb complex PRC2 and its mark in life

Raphael Margueron et al.

NATURE (2011)

Article Multidisciplinary Sciences

Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors

JI Koontz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)